![Kimberly Blackwell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Kimberly L.
Blackwell is the founder of Cereius, Inc., established in 2017, serving as President.
Current jobs include Director at Fore Biotherapeutics, Inc. since 2021, Independent Director at Century Therapeutics, Inc. since 2021, and Independent Director at Monte Rosa Therapeutics, Inc. since 2020.
Former jobs include Director at Neoantigenics, Inc., Director-Women's Cancer Program & Professor at Duke Cancer Institute from 1997 to 2018, Director at Century Therapeutics, Inc. in 2021, Director, Chief Executive & Medical Officer at Zentalis Pharmaceuticals, Inc. from 2020 to 2024, VP-Early Phase Oncology & Immuno-Oncology at Eli Lilly & Co. from 2018 to 2020, Professor at Duke University from 1997 to 2018, Vice President-Early Phase Oncology at Lilly Oncology, and Chief Medical Officer & SVP-Clinical Oncology at Tempus AI, Inc. from 2020 to 2022.
Education includes undergraduate degree from Duke University and doctorate from Mayo Clinic College of Medicine & Science.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/06/2020 |
| CENTURY THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2021 |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Direttore/Membro del Consiglio | 20/09/2021 |
Cereius, Inc.
 Cereius, Inc. BiotechnologyHealth Technology Develops novel radio-labeled therapeutics for treating solid tumor brain metastasis | Fondatore | 01/01/2017 |
| Società | Posizione | Fine |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Amministratore Delegato | 13/11/2024 |
| TEMPUS AI, INC. | Direttore Tecnico/Scientifico/R&S | 16/05/2022 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/03/2020 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2018 |
Duke Cancer Institute
 Duke Cancer Institute Hospital/Nursing ManagementHealth Services Operates cancer center | Corporate Officer/Principal | 01/01/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neoantigenics, Inc.
 Neoantigenics, Inc. Medical SpecialtiesHealth Technology Developes therapeutic plus diagnostic products | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Mayo Clinic College of Medicine & Science
 Mayo Clinic College of Medicine & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
Tempus AI, Inc.
 Tempus AI, Inc. Packaged SoftwareTechnology Services Develops clinical & molecular data platform for healthcare | Technology Services |
Duke Cancer Institute
Duke Cancer Institute Hospital/Nursing ManagementHealth Services Operates cancer center | Health Services |
Cereius, Inc.
Cereius, Inc. BiotechnologyHealth Technology Develops novel radio-labeled therapeutics for treating solid tumor brain metastasis | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
